AZD 3965
To Order Contact us: stephen@expresspharmapulse.com
AZD-3463 |
|||
| HY-15609 | MedChemExpress | 100mg | EUR 782 |
AZD-5069 |
|||
| HY-19855 | MedChemExpress | 5mg | EUR 153 |
AZD-6280 |
|||
| HY-19872 | MedChemExpress | 20mg | EUR 3356 |
AZD-8055 |
|||
| HY-10422 | MedChemExpress | 200mg | EUR 505 |
AZD-7762 |
|||
| HY-10992 | MedChemExpress | 100mg | EUR 695 |
AZD 9272 |
|||
| HY-110254 | MedChemExpress | 5mg | EUR 142 |
AZD 2066 |
|||
| HY-110255 | MedChemExpress | 5mg | EUR 383 |
AZD-0364 |
|||
| HY-111483 | MedChemExpress | 50mg | EUR 2002 |
AZD-7648 |
|||
| HY-111783 | MedChemExpress | 10mg | EUR 223 |
AZD-0284 |
|||
| HY-120384 | MedChemExpress | 100mg | EUR 3896 |
AZD-8835 |
|||
| HY-12869 | MedChemExpress | 25mg | EUR 337 |
AZD-2461 |
|||
| HY-13536 | MedChemExpress | 10mM/1mL | EUR 126 |
AZD-5438 |
|||
| HY-10012 | MedChemExpress | 10mg | EUR 133 |
AZD-5991 |
|||
| HY-101533 | MedChemExpress | 5mg | EUR 452 |
AZD-1480 |
|||
| HY-10193 | MedChemExpress | 5mg | EUR 119 |
AZD 6482 |
|||
| HY-10344 | MedChemExpress | 10mM/1mL | EUR 254 |
AZD 4407 |
|||
| HY-U00217 | MedChemExpress | 10mg | EUR 3700 |
Azd-9291 |
|||
| abx183859-100mg | Abbexa | 100 mg | EUR 676 |
AZD 5153 |
|||
| C3076-10 | ApexBio | 10 mg | EUR 383 |
|
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM. |
|||
AZD 5153 |
|||
| C3076-25 | ApexBio | 25 mg | EUR 728 |
|
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM. |
|||
AZD 5153 |
|||
| C3076-5 | ApexBio | 5 mg | EUR 248 |
|
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM. |
|||
AZD 3988 |
|||
| B4944-10 | ApexBio | 10 mg | EUR 583 |
AZD 3988 |
|||
| B4944-50 | ApexBio | 50 mg | EUR 2225 |
AZD-5597 |
|||
| B5926-25 | ApexBio | 25 mg | EUR 1442 |
|
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1]. |
|||
AZD-5597 |
|||
| B5926-5 | ApexBio | 5 mg | EUR 456 |
|
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1]. |
|||
AZD-5597 |
|||
| B5926-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 618 |
|
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1]. |
|||
AZD-9291 |
|||
| B1104-10 | ApexBio | 10 mg | EUR 160 |
|
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR. |
|||
AZD-9291 |
|||
| B1104-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 154 |
|
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR. |
|||
AZD-9291 |
|||
| B1104-50 | ApexBio | 50 mg | EUR 340 |
|
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR. |
|||
AZD-9291 |
|||
| B1104-500 | ApexBio | 500 mg | EUR 1186 |
|
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR. |
|||
AZD-5438 |
|||
| A8326-10 | ApexBio | 10 mg | EUR 119 |
|
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively. |
|||
AZD-5438 |
|||
| A8326-100 | ApexBio | 100 mg | EUR 502 |
|
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively. |
|||
AZD-5438 |
|||
| A8326-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 125 |
|
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively. |
|||
AZD-5438 |
|||
| A8326-50 | ApexBio | 50 mg | EUR 305 |
|
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively. |
|||
AZD-3463 |
|||
| A8620-10 | ApexBio | 10 mg | EUR 224 |
|
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma. |
|||
AZD-3463 |
|||
| A8620-100 | ApexBio | 100 mg | EUR 667 |
|
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma. |
|||
AZD-3463 |
|||
| A8620-5 | ApexBio | 5 mg | EUR 160 |
|
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma. |
|||
AZD-3463 |
|||
| A8620-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 177 |
|
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma. |
|||
AZD-3463 |
|||
| A8620-50 | ApexBio | 50 mg | EUR 471 |
|
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma. |
|||
AZD-8186 |
|||
| B1027-25 | Biovision | EUR 756 | |
AZD-8186 |
|||
| B1027-5 | Biovision | EUR 229 | |
AZD-6482 |
|||
| B1143-25 | Biovision | EUR 675 | |
AZD-6482 |
|||
| B1143-5 | Biovision | EUR 207 | |
AZD-6738 |
|||
| B1167-25 | Biovision | EUR 588 | |
AZD-6738 |
|||
| B1167-5 | Biovision | EUR 196 | |
AZD-0156 |
|||
| B1305-25 | Biovision | EUR 512 | |
AZD-0156 |
|||
| B1305-5 | Biovision | EUR 175 | |
AZD-5363 |
|||
| B1762-25 | Biovision | EUR 588 | |
AZD-5363 |
|||
| B1762-5 | Biovision | EUR 185 | |
AZD-4635 |
|||
| B2012-25 | Biovision | EUR 756 | |
AZD-4635 |
|||
| B2012-5 | Biovision | EUR 229 | |
AZD-5153 |
|||
| B2020-25 | Biovision | EUR 865 | |
AZD-5153 |
|||
| B2020-5 | Biovision | EUR 262 | |
AZD-5069 |
|||
| B2053-25 | Biovision | EUR 675 | |
AZD-5069 |
|||
| B2053-5 | Biovision | EUR 207 | |
AZD-5438 |
|||
| B2073-25 | Biovision | EUR 544 | |
AZD-5438 |
|||
| B2073-5 | Biovision | EUR 175 | |
AZD-5582 |
|||
| B2362-1 | Biovision | EUR 131 | |
AZD-5582 |
|||
| B2362-5 | Biovision | EUR 370 | |
AZD-3229 |
|||
| B2513-1 | Biovision | EUR 175 | |
AZD-3229 |
|||
| B2513-5 | Biovision | EUR 512 | |
AZD-4547 |
|||
| 9403-25 | Biovision | EUR 457 | |
AZD-4547 |
|||
| 9403-5 | Biovision | EUR 153 | |
AZD-7762 |
|||
| 9414-25 | Biovision | EUR 414 | |
AZD-7762 |
|||
| 9414-5 | Biovision | EUR 142 | |
AZD-2014 |
|||
| 9449-25 | Biovision | EUR 544 | |
AZD-2014 |
|||
| 9449-5 | Biovision | EUR 175 | |
AZD-3759 |
|||
| 9609-25 | Biovision | EUR 631 | |
AZD-3759 |
|||
| 9609-5 | Biovision | EUR 196 | |
AZD-1981 |
|||
| 9611-25 | Biovision | EUR 631 | |
AZD-1981 |
|||
| 9611-5 | Biovision | EUR 196 | |
AZD-8931 |
|||
| 9659-25 | Biovision | EUR 620 | |
AZD-8931 |
|||
| 9659-5 | Biovision | EUR 207 | |
AZD-3463 |
|||
| 2371-25 | Biovision | EUR 457 | |
AZD-3463 |
|||
| 2371-5 | Biovision | EUR 153 | |
AZD-9291 |
|||
| 2674-25 | Biovision | EUR 457 | |
AZD-9291 |
|||
| 2674-5 | Biovision | EUR 153 | |
AZD-1283 |
|||
| 2838-25 | Biovision | EUR 457 | |